Doç. Dr. Onur Dülgeroğlu
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 6 publicationsSource: OpenAlex / PubMed MeSHView publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Obezite Cerrahisi
- Obezite
- Tiroid Hastalıkları ve Tedavisi
- Endokrin Cerrahisi
- Gastrik Bypass
- Mastektomi
- Tüp Mide Ameliyatı
- Tiroid Cerrahisi
- Meme Büyütme Ameliyatı
- Meme Hastalıkları
- Meme Kanseri
- Obezite Tedavisi
CV
Education and experience
Experience
- 2016Acıbadem Sağlık Grubuacibadem.com.tr
- 2014 - 2016Kars Devlet Hastanesi (Mecburi Hizmet)acibadem.com.tr
Education
- 2014İzmir Katip Çelebi Üniversitesi - Atatürk Eğitim ve Araştırma Hastanesi, Genel Cerrahi, Uzmanlıkacibadem.com.tr
- 2004Ondokuzmayıs Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyGeneral Surgeryacibadem.com.trFrom source
- Department name at the sourceMeme Kliniği, Obezite Tedavisi, Obezite Cerrahisi, Tiroid Hastalıkları ve Tedavisi, Obezite Ünitesiacibadem.com.trFrom source
- InstitutionAcıbadem Atakent Hastanesiacibadem.com.trFrom source
- Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
- Publications30 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 21:04https://www.acibadem.com.tr/doktor/onur-dulgeroglu/acibadem.com.tr
Scientific work
Publications on Breast Neoplasms
-
Potential role of AI decision support in reducing unnecessary ultrasound-guided breast biopsies
The Egyptian Journal of Radiology and Nuclear Medicine, 2026
DOI 10.1186/s43055-026-01684-5 Source: OpenAlex
-
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology
European Journal of Breast Health, 2026
DOI 10.4274/ejbh.galenos.2026.2025-10-1 PMID 41873792 Open-access full textSource: OpenAlex
-
Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases
Cancers, 2026
DOI 10.3390/cancers18111760 PMID 42279343 Open-access full textSource: OpenAlex
-
Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15187136 PMID 42795909 Open-access full textSource: OpenAlex
-
Concordance Between AI-generated Recommendations and Multidisciplinary Tumor Board Decisions in Postoperative Breast Cancer Management: A Retrospective Validation Study
Turkish Journal of Surgical Oncology, 2026
DOI 10.4274/turkjsurgoncol.galenos.2026.69885 Open-access full textSource: OpenAlex
-
MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer—a retrospective multi-center study analysis
Updates in Surgery, 2026
DOI 10.1007/s13304-025-02513-6 PMID 41790369 Open-access full textSource: OpenAlex
-
Concomitant Cholecystectomy During Bariatric Surgery: Surgical Technique and Safety
Journal of Laparoendoscopic & Advanced Surgical Techniques, 2026
DOI 10.1177/10926429261491052 PMID 42802608 Source: OpenAlex
-
Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study
Clinical Cancer Research, 2025
DOI 10.1158/1557-3265.sabcs24-p3-07-10 Source: OpenAlex
-
Abstract P3-07-14: Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study
Clinical Cancer Research, 2025
DOI 10.1158/1557-3265.sabcs24-p3-07-14 Source: OpenAlex
-
Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study
European Journal of Surgical Oncology, 2025
DOI 10.1016/j.ejso.2025.109642 PMID 40009910 5 citations (Europe PMC) Source: OpenAlex